FDA Approved: AMITRIPTYLINE HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application for Amitriptyline Hydrochloride from Aurobindo Pharma Limited, authorizing a generic product's approval under an ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Migraine
• Neuropathic Pain

Drugs mentioned

• Amitriptyline hydrochloride (amitriptyline hydrochloride)

Snippet

SUPPL AP for AMITRIPTYLINE HYDROCHLORIDE (AMITRIPTYLINE HYDROCHLORIDE)